Search by Drug Name or NDC

    NDC 00067-7918-06 THERAFLU 650; 25; 10 mg/237mL; mg/237mL; mg/237mL Details

    THERAFLU 650; 25; 10 mg/237mL; mg/237mL; mg/237mL

    THERAFLU is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00067-7918
    Product ID 0067-7918_098627cf-f89e-2a19-e063-6394a90ab53f
    Associated GPIs 43994003903045
    GCN Sequence Number 064453
    GCN Sequence Number Description diphenhyd/phenyleph/acetaminop POWD PACK 25-10-650 ORAL
    HIC3 B3O
    HIC3 Description 1ST GEN ANTIHISTAMINE-DECONGESTANT-ANALGESIC COMB
    GCN 14359
    HICL Sequence Number 035433
    HICL Sequence Number Description DIPHENHYDRAMINE HCL/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Brand
    Proprietary Name THERAFLU
    Proprietary Name Suffix NIGHTTIME SEVERE COLD AND COUGH
    Non-Proprietary Name ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL
    Product Type HUMAN OTC DRUG
    Dosage Form POWDER, FOR SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 25; 10
    Active Ingredient Units mg/237mL; mg/237mL; mg/237mL
    Substance Name ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M012
    Listing Certified Through 2024-12-31

    Package

    NDC 00067-7918-06 (00067791806)

    NDC Package Code 0067-7918-06
    Billing NDC 00067791806
    Package 6 PACKET in 1 CARTON (0067-7918-06) / 237 mL in 1 PACKET (0067-7918-01)
    Marketing Start Date 2014-07-01
    NDC Exclude Flag N
    Pricing Information N/A